Finanzwire Finanzwire
Basculer en Français
10827 Companies
234901 Keywords
163761 Articles
125733 Press releases
Headlines Articles Press releases NeuroEM Therapeutics Remove
  1. Home
  2. Companies
  3. NeuroEM Therapeutics
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/19/2024 at 14:35, 1 year 10 months ago

    NeuroEM Therapeutics Accepted into StartUp Health's Alzheimer's Moonshot Community

    NeuroEM Therapeutics Alzheimer's Moonshot Transcranial Electromagnetic Treatment Gates Ventures ADDF
  • PRESS RELEASE

    published on 09/19/2024 at 14:30, 1 year 10 months ago

    NeuroEM Therapeutics(R) Accepted into StartUp Health's Alzheimer's Moonshot Community(TM)

    NeuroEM Therapeutics joins StartUp Health's Alzheimer's Moonshot Community to accelerate innovation in Alzheimer's care. Cutting-edge TEMT-RF technology aims to prevent and treat cognitive decline
    NeuroEM Therapeutics StartUp Health Alzheimer's Moonshot Community TEMT-RF Technology Cognitive Decline
    Logo of NeuroEM Therapeutics
  • PRESS RELEASE

    published on 11/16/2023 at 19:30, 2 years 8 months ago

    NeuroEM Therapeutics Emerges from Chapter 11 with a Stronger Vision, New Leadership, and Renewed Focus on Growth

    Logo of NeuroEM Therapeutics
Accesswire
  • Published on 08/13/2026 at 00:30, 15 minutes ago

    Aton Closes CAD$4 Million Private Placement

  • Published on 08/12/2026 at 23:30, 1 hour 15 minutes ago

    CCL Industries Announces Record Results for 2026 Second Quarter

  • Published on 08/12/2026 at 23:30, 1 hour 15 minutes ago

    Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle

  • Published on 08/12/2026 at 23:20, 1 hour 25 minutes ago

    RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement

  • Published on 08/12/2026 at 23:05, 1 hour 40 minutes ago

    Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend

View all ACCESSWIRE
EQS Group
  • Published on 08/12/2026 at 21:05, 3 hours 39 minutes ago

    Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA

  • Published on 08/12/2026 at 19:57, 4 hours 47 minutes ago

    EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million

  • Published on 08/12/2026 at 19:37, 5 hours 7 minutes ago

    EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged

  • Published on 08/12/2026 at 18:50, 5 hours 55 minutes ago

    Holding(s) in Company

  • Published on 08/12/2026 at 18:29, 6 hours 16 minutes ago

    Designated Persons Notifications

View all EQS
Les Echos
  • Published on 08/10/2026 at 18:00, 2 days 6 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 17:45, 2 days 7 hours ago

    Weekly share buyback

  • Published on 08/10/2026 at 11:53, 2 days 12 hours ago

    GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

  • Published on 08/10/2026 at 11:36, 2 days 13 hours ago

    GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026

  • Published on 08/10/2026 at 09:22, 2 days 15 hours ago

    Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy